Taysha Gene Therapies, Inc. (TSHA) Financials

$1.57

north_east
$0.04 (2.6%)
Day's range
$1.47
Day's range
$1.57
Profit Margin
Revenue
Earnings
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200MEarning20192019202020202021202120222022202320230%0%-2000%-2000%-4000%-4000%-6000%-6000%-8000%-8000%-10000%-10000%Profit Margin

TSHA Income statement / Annual

Last year (2023), Taysha Gene Therapies, Inc.'s total revenue was $15.45 M, an increase of 517.55% from the previous year. In 2023, Taysha Gene Therapies, Inc.'s net income was -$111.57 M. See Taysha Gene Therapies, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $15.45 M $2.50 M $0.00 $0.00 $0.00
Cost of Revenue $0.00 $2.49 M $492,000.00 $9,000.00 $0.00
Gross Profit $15.45 M $15,000.00 -$492,000.00 -$9,000.00 $0.00
Gross Profit Ratio 1 0.01 0 0 0
Research and Development Expenses $56.78 M $91.17 M $131.94 M $31.89 M $987,000.00
General & Administrative Expenses $30.05 M $37.36 M $41.32 M $11.11 M $512,000.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 -$384,000.00
Selling, General & Administrative Expenses $30.05 M $37.36 M $41.32 M $11.11 M $128,000.00
Other Expenses $1.07 M -$18,000.00 $0.00 -$17.03 M $0.00
Operating Expenses $87.89 M $128.53 M $173.27 M $43.00 M $1.12 M
Cost And Expenses $87.89 M $128.53 M $173.27 M $43.00 M $1.12 M
Interest Income $3.57 M $249,000.00 $172,000.00 $49,000.00 $0.00
Interest Expense $5.00 M $3.80 M $1.43 M $28,000.00 $0.00
Depreciation & Amortization $1.37 M $2.49 M $492,000.00 $9,000.00 $4.46 M
EBITDA -$105.20 M -$159.73 M -$172.78 M -$42.99 M $0.00
EBITDA Ratio -6.81 -50.28 0 0 0
Operating Income Ratio -4.69 -64.93 0 0 0
Total Other Income/Expenses Net -$39.13 M -$3.57 M -$1.26 M -$17.01 M $0.00
Income Before Tax -$111.57 M -$166.01 M -$174.52 M -$60.01 M -$1.12 M
Income Before Tax Ratio -7.22 -66.35 0 0 0
Income Tax Expense $0.00 $3.57 M $936,000.00 -$17.01 M -$4.46 M
Net Income -$111.57 M -$169.58 M -$175.46 M -$43.00 M -$1.12 M
Net Income Ratio -7.22 -67.78 0 0 0
EPS -0.96 -3.86 -4.66 -2.43 -0.0301
EPS Diluted -0.96 -3.86 -4.66 -2.43 -0.0301
Weighted Average Shares Out $116.12 M $43.95 M $37.65 M $17.67 M $36.99 M
Weighted Average Shares Out Diluted $116.12 M $43.95 M $37.65 M $17.67 M $36.99 M
Link